Ensuring that the right patients get the right treatments at the right time

Data Analytics & Epidemiology

Mapi’s talent pool of scientists includes a number of epidemiologists and outcomes research scientists who are deeply familiar with secondary data sources around the globe. Clients who wish to understand the real-world use of their products in the most naturalistic, cost-effective, and time-efficient way are keenly interested in tapping these rich data sources to profile burden of illness, patterns of use, and even prescriber or patient experiences when the latter can be surveyed.

Mapi’s expert team advises clients on the optimal data sources to employ, depending on the outcomes and the markets of interest. Our strategy often begins with a comprehensive database/data source ‘mapping’ to identify secondary data resources, ending with an elegant evaluation of the identified data sources. Our experts also understand limitations of secondary data resources for some research objectives, and can advise alternative strategies such as hybrid study designs to ensure research goals are met.

Additionally, Mapi’s epidemiologists have a laser focus on patient safety and a great deal of experience with US REMS and EU-RMP design, implementation, and effectiveness assessments. All of Mapi’s epidemiologists, outcomes research scientists, and analysts are trained in the art and the science of robust literature reviews; whether clients need a simple (and rapid) safety review, structured or systematic literature review, or full meta-analysis, Mapi’s team delivers robust results.

Request a consultation with an RWS&A expert